ClinicalTrials.gov record
Completed Phase 4 Interventional

Antidepressant Therapy for Bipolar II Major Depression

ClinicalTrials.gov ID: NCT00641927

Public ClinicalTrials.gov record NCT00641927. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 10:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Acute Antidepressant Therapy in Bipolar II Major Depression

Study identification

NCT ID
NCT00641927
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Stanley Medical Research Institute
Other
Enrollment
90 participants

Conditions and interventions

Interventions

  • Lithium Carbonate Drug
  • Venlafaxine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2002
Primary completion
Sep 30, 2006
Completion
Sep 30, 2006
Last update posted
Mar 23, 2008

2002 – 2006

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Depression Research Unit, Department of Psychiatry, University of Pennsylvania Philadelphia Pennsylvania 19104-3309

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00641927, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 23, 2008 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00641927 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →